New study investigates cannabis use in cancer immunotherapy patients

NCT ID NCT06206941

Recruiting now Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 25 times

Summary

This study looks at how cannabis affects symptoms like pain, sleep, and anxiety in 450 adults with cancer who are receiving immunotherapy. Participants will complete surveys and daily check-ins over a year. The goal is to understand if cannabis helps or causes harm, so doctors can better guide patient care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Oregon Health and Science University
NOT_YET_RECRUITING

Portland, Oregon, 97239, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Thomas Jefferson University
RECRUITING

Philadelphia, Pennsylvania, 19107, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CANCER